A six-case retrospective study found follicular dendritic cell sarcoma arising from Castleman disease was frequently ...
A new review links EBV-driven lymphoproliferative disorders to disrupted DNA methylation and outlines emerging epigenetic ...
An expert discusses infection risks after treatment, what follow-up care looks like and why patients with a rare cancer ...
Researchers are exploring new options for patients with relapsed or refractory hairy cell leukemia, including chimeric ...
Daily News on MSN
Several new benefits added to Suraksha Student Insurance Programme
Sri Lanka, Oct. 21 -- The Cabinet of Ministers on Monday (19) granted approval to revise and implement the existing agreement on the Suraksha Student Insurance Programme, adding several new benefits ...
The convention will be called MSToronto2026, a shortened name replacing earlier, longer titles such as the global meeting of ...
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients ...
Pierre Fabre Pharmaceuticals Inc. (PFP) announces the acceptance by U.S. Food and Drug Administration (FDA) of the Biologics License Application (BLA) resubmission for tabelecleucel, with a proposed ...
Several biotech and healthcare stocks moved sharply higher, driven by company-specific developments including financing activity, regulatory updates and strategic initiatives. NewGen IVF Group Ltd.
Patients' responses to questions routinely raised by oncologists may provide important clues about their chances of survival from chronic lymphocytic leukemia (CLL), according to a new study published ...
Adults with incidentally detected vertebral fractures have an increased relative risk of myeloma, although their absolute five-year risk is modest, according to a research letter published online Sept ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results